Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrially encoded cytochrome b pseudogene 19 (MTCYBP19) is a non-protein-coding sequence in the human genome classified as a *pseudogene* of the MT-CYB gene[6]. Unlike the canonical MT-CYB gene, which encodes cytochrome b and is critical for mitochondrial energy production and disease relevance[1][3][7], MTCYBP19 does not code for a functional protein and does not play a role in mitochondrial electron transport or related diseases. There are no established biological functions, disease associations, drug interactions, or biomarkers related to MTCYBP19. It should not be confused with MT-CYB, which is a key mitochondrial enzyme and sometimes a clinical or research target.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded cytochrome b pseudogene 19 (MTCYBP19).